(Q24302165)

negative regulation of tau-protein kinase activity

GO:1902996

1 reference

negative regulation of neurofibrillary tangle assembly

GO:1902948

1 reference

positive regulation of tau-protein kinase activity

GO:1902997

1 reference

neurofibrillary tangle assembly

GO:1902949

1 reference

regulation of tau-protein kinase activity

GO:1902988

1 reference

positive regulation of neurofibrillary tangle assembly

GO:1902947

2 references

GO:1902998

GOA release 2020-03-11

Clusterin

1 reference

Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation

GOA release 2020-03-11

1 reference

M D Martin-Rehrmann

1

0 references

H-S Hoe

series ordinal

2

0 references

E M Capuani

series ordinal

3

0 references

G W Rebeck

series ordinal

4

0 references

language of work or name

English

0 references

publication date

2005

0 references

published in

Neurotoxicity Research

0 references

volume

7

0 references

issue

3

0 references

page(s)

231-42

0 references

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03036452

The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03036452

Apolipoprotein J and Alzheimer's amyloid beta solubility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03036452

Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03036452

Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03036452

Sequence of Abeta-protein deposition in the human medial temporal lobe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03036452

Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2/megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide

21 January 2018

1 reference

12 December 2020

The Alzheimer family of diseases: many etiologies, one pathogenesis?

1 reference

12 December 2020

Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.

1 reference

12 December 2020

Characterization of apolipoprotein J-Alzheimer's A beta interaction

1 reference

12 December 2020

Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.

1 reference

12 December 2020

Clinical and pathological correlates of apolipoprotein E ?4 in Alzheimer's disease

1 reference

12 December 2020

Correlations of synaptic and pathological markers with cognition of the elderly

1 reference

12 December 2020

Possible neuroprotective role of clusterin in Alzheimer's disease: a quantitative immunocytochemical study

1 reference

12 December 2020

Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease

1 reference

12 December 2020

Clusterin (Apo J) protects against in vitro amyloid-beta (1-40) neurotoxicity

1 reference

12 December 2020

Expression of apolipoprotein E mRNA in rat microglia

1 reference

12 December 2020

The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease

1 reference

12 December 2020

Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels.

1 reference

12 December 2020

Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP(V717F) transgenic mice.

1 reference

12 December 2020

Deposition of apolipoproteins E and J in senile plaques is topographically determined in both Alzheimer's disease and Down's syndrome brain

1 reference

12 December 2020

Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease

1 reference

12 December 2020

SP-40,40 is a constituent of Alzheimer's amyloid

1 reference

12 December 2020

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

1 reference

12 December 2020

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

1 reference

12 December 2020

Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease.

1 reference

12 December 2020

Distribution of clusterin in Alzheimer brain tissue

1 reference

12 December 2020

Clusterin contributes to caspase-3-independent brain injury following neonatal hypoxia-ischemia.

1 reference

12 December 2020

Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.

1 reference

12 December 2020

Co-localization of cholesterol, apolipoprotein E and fibrillar Abeta in amyloid plaques

1 reference

12 December 2020

Apolipoproteins J and E co-localise with amyloid in gelatinous drop-like and lattice type I corneal dystrophies.

1 reference

12 December 2020

Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins

1 reference

12 December 2020

Reduction of lipofuscin-like autofluorescence in fluorescently labeled tissue

1 reference

12 December 2020

alpha 2-Macroglobulin exposure reduces calcium responses to N-methyl-D-aspartate via low density lipoprotein receptor-related protein in cultured hippocampal neurons

1 reference

12 December 2020

Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease

1 reference

12 December 2020

Aggregation and disaggregation of senile plaques in Alzheimer disease

1 reference

12 December 2020

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

1 reference

12 December 2020

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

1 reference

12 December 2020

Reduction in amyloid A amyloid formation in apolipoprotein-E-deficient mice

1 reference

12 December 2020